Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to -$8.4 million.

  • PROCEPT BioRobotics' Net Cash Flow rose 5138.19% to -$8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.6 million, marking a year-over-year increase of 20708.0%. This contributed to the annual value of $76.5 million for FY2024, which is 12119.64% up from last year.
  • Per PROCEPT BioRobotics' latest filing, its Net Cash Flow stood at -$8.4 million for Q3 2025, which was up 5138.19% from -$13.5 million recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' Net Cash Flow ranged from a high of $161.3 million in Q3 2021 and a low of -$40.9 million during Q1 2023
  • Over the past 5 years, PROCEPT BioRobotics' median Net Cash Flow value was -$16.2 million (recorded in 2021), while the average stood at $10.3 million.
  • Within the past 5 years, the most significant YoY rise in PROCEPT BioRobotics' Net Cash Flow was 76735.96% (2023), while the steepest drop was 14058.25% (2023).
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' Net Cash Flow stood at -$16.2 million in 2021, then tumbled by 69.25% to -$27.4 million in 2022, then dropped by 12.0% to -$30.6 million in 2023, then skyrocketed by 546.98% to $137.0 million in 2024, then tumbled by 106.15% to -$8.4 million in 2025.
  • Its Net Cash Flow stands at -$8.4 million for Q3 2025, versus -$13.5 million for Q2 2025 and -$17.5 million for Q1 2025.